Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28092030

CC(C)(C)OC=O.CC1(NC(=O)OCc2ccccc2)CCNCC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TLR2 O60603 2/20 0.42
CTSB P07858 3/20 0.42
CTSS P25774 3/20 0.42
CTSL P07711 2/20 0.42
ITGB3 P05106 2/20 0.41
ITGA2B P08514 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
SYK P43405 1/20 0.39
CTSK P43235 2/20 0.39
RORC P51449 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ITGAV P06756 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL606307 0.89 CTSB (0.49) TLR2CTSBCTSSCTSLSMN1; SMN2
Hydrochloric Acid SCHEMBL606498 0.88 TLR2 (0.49) TLR2CTSBCTSSCTSLSMN1; SMN2
SCHEMBL22495659 0.85 CTSS (0.48) TLR2CTSBCTSSCTSLSMN1; SMN2
Tert-Butyl Formate SCHEMBL28269418 0.83 KYNU (0.39) TLR2CTSBCTSSCTSLITGB3
SCHEMBL9837644 0.82 CTSB (0.47) TLR2CTSBCTSSCTSLSMN1; SMN2
Hydrochloric Acid SCHEMBL28650823 0.81 CTSB (0.46) TLR2CTSBCTSSCTSLSMN1; SMN2
SCHEMBL14743992 0.80 CTSL (0.54) CTSBCTSSCTSLSMN1; SMN2NPC1
SCHEMBL27778874 0.80 CA12 (0.46) TLR2CTSBCTSSCTSLSMN1; SMN2
Tert-Butyl Formate SCHEMBL27955423 0.79 ALDH1A1 (0.56) CTSBCTSLITGB3ITGA2BCTSK
SCHEMBL18793707 0.78 CTSB (0.55) CTSBCTSSCTSLSMN1; SMN2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008466-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2018-12-14 CN disclosed
CN-106008466-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 艾伯维公司 2016-10-12 CN disclosed
CN-102307622-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2016-08-17 CN disclosed